United Kingdom

People: Stryker Corp (SYK.N)

SYK.N on New York Stock Exchange

9:02pm BST
Change (% chg)

$-1.43 (-0.70%)
Prev Close
Day's High
Day's Low
Avg. Vol
52-wk High
52-wk Low

Scannell, Timothy 

Mr. Timothy J. Scannell is President, Chief Operating Officer of the Company effective August 1, 2018. He began his career with Stryker’s Endoscopy business in 1990 where he served in sales and marketing leadership roles. He then took on roles of increased responsibility spanning many of our businesses and has served as a Group President for nearly a decade, most recently overseeing MedSurg & Neurotechnology. Mr. Scannell serves on the Board of Directors for Insulet Corporation.

Basic Compensation

Total Annual Compensation, USD 631,667
Restricted Stock Award, USD 1,910,860
Long-Term Incentive Plans, USD --
All Other, USD 2,116,540
Fiscal Year Total, USD 4,659,060

Options Compensation

  Quantity Market Value
Exercisable -- --
Unexercisable -- --
Exercised 85,000 8,021,450.00